Key Takeaways
- • PIF increased US equity portfolio to $23.8 billion in Q2 2025, up $3.2 billion (15.5%) from $20.6 billion a year earlier, with positions expanding from 38 to 57 equities and options according to SEC Form-13F filings.
- • Strategic sector rotation: exited consumer tech and e-commerce entirely, divesting stakes in Meta, PayPal, Alibaba, and Shopify while concentrating capital in semiconductors and healthcare—doubling Arm Holdings stake and adding UnitedHealth, Eli Lilly, and Merck.
- • Lucid Group received extraordinary capital infusion, with PIF boosting its position by nearly 400 million shares, signaling aggressive support for the EV manufacturer despite broader tech sector pullback.
- • PIF's overall performance declined sharply in 2024, with net profit falling 60% to SR26 billion amid higher interest rates and project delays, prompting shift toward revenue-generating assets rather than speculative positions.
- • PIF remains world's fourth-largest sovereign wealth fund with $1.15 trillion in assets under management as of 2025, operating under Saudi Arabia's Vision 2030 diversification mandate balancing financial returns with domestic economic transformation.
Summary
Saudi Arabia's Public Investment Fund expanded its US equity footprint to $23.8 billion in the second quarter of 2025, marking a $3.2 billion increase from the prior year, according to its latest SEC Form-13F filing. The expansion reflects not merely portfolio growth but a fundamental reorientation of capital allocation, with PIF nearly doubling the number of equity positions from 38 to 57 holdings across options and equities.
The fund's most striking moves involved wholesale exits from consumer-facing technology and e-commerce names, including complete or near-complete divestment from Meta, PayPal, Alibaba, and Shopify. Simultaneously, PIF executed a marked concentration into semiconductors and healthcare infrastructure. Most dramatically, the fund increased its Lucid Group position by approximately 400 million shares, demonstrating sustained conviction in the electric-vehicle sector despite broader market volatility. PIF more than doubled its Arm Holdings stake, added positions in chip equipment supplier ASML and analog semiconductor specialist Analog Devices, and established or expanded healthcare holdings in UnitedHealth, Eli Lilly, and Merck—signaling a defensive pivot toward established, revenue-generating enterprises in critical industries.
As the operational arm of Saudi Arabia's Vision 2030 economic diversification strategy, PIF operates under a dual mandate balancing shareholder returns with domestic economic transformation. The fund channels capital into both global securities markets and domestic sectors including tourism, infrastructure, and technology. However, financial headwinds in 2024 forced operational discipline: net profit contracted 60% to SR26 billion, pressured by elevated interest rates, asset impairments, and project delays. In response, PIF tightened performance management protocols, raised liquidity through commercial paper and sukuk issuance, and explicitly shifted focus toward revenue-generating assets—a strategic repositioning visible in the US equity portfolio's transition away from growth-stage consumer platforms toward defensive healthcare and critical semiconductor capabilities.
With assets under management reaching $1.15 trillion in 2025, PIF ranks as the world's fourth-largest sovereign wealth fund by Global SWF data. The current portfolio rebalancing reflects institutional capital responding to macroeconomic conditions while maintaining long-term exposure to secular themes—semiconductor demand and healthcare spending—essential to both financial returns and global economic positioning.
The fund's most striking moves involved wholesale exits from consumer-facing technology and e-commerce names, including complete or near-complete divestment from Meta, PayPal, Alibaba, and Shopify. Simultaneously, PIF executed a marked concentration into semiconductors and healthcare infrastructure. Most dramatically, the fund increased its Lucid Group position by approximately 400 million shares, demonstrating sustained conviction in the electric-vehicle sector despite broader market volatility. PIF more than doubled its Arm Holdings stake, added positions in chip equipment supplier ASML and analog semiconductor specialist Analog Devices, and established or expanded healthcare holdings in UnitedHealth, Eli Lilly, and Merck—signaling a defensive pivot toward established, revenue-generating enterprises in critical industries.
As the operational arm of Saudi Arabia's Vision 2030 economic diversification strategy, PIF operates under a dual mandate balancing shareholder returns with domestic economic transformation. The fund channels capital into both global securities markets and domestic sectors including tourism, infrastructure, and technology. However, financial headwinds in 2024 forced operational discipline: net profit contracted 60% to SR26 billion, pressured by elevated interest rates, asset impairments, and project delays. In response, PIF tightened performance management protocols, raised liquidity through commercial paper and sukuk issuance, and explicitly shifted focus toward revenue-generating assets—a strategic repositioning visible in the US equity portfolio's transition away from growth-stage consumer platforms toward defensive healthcare and critical semiconductor capabilities.
With assets under management reaching $1.15 trillion in 2025, PIF ranks as the world's fourth-largest sovereign wealth fund by Global SWF data. The current portfolio rebalancing reflects institutional capital responding to macroeconomic conditions while maintaining long-term exposure to secular themes—semiconductor demand and healthcare spending—essential to both financial returns and global economic positioning.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.